XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
  Anti-Inflammatory
  Antivirals
  Antihypertensives
  Anticholesterol
  Anti-Clotting Drugs
  Anti Cancer Drugs
  Hypnotics
  PPI
  Antibiotics
  Analgesics
  Surfactants
  Fatty Acids
  Adrenergics
  Metals
  Varenicline
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Pharmacology Channel
subscribe to Pharmacology newsletter

Latest Research : Pharmacology

   DISCUSS   |   EMAIL   |   PRINT
Enzymes to catalyse new drug production
Apr 15, 2006, 09:28, Reviewed by: Dr. Vineet Gupta

Modern drugs are designed to have structures that stick to enzymes and prevent them from catalysing the reactions, so our results need to be taken into account when designing new drugs

 
Groundbreaking research published in journal Science could revolutionise the way drugs are made and have major implications for the industrial sector, say its authors.

The University of Manchester team, working with colleagues in Bristol, has provided a unique insight into the working of enzymes � biological molecules that speed up chemical reactions in the body.

When these chemical reactions go wrong they can lead to disease, so modern drugs are designed to target enzymes and 'switch them off'.

But their ability to accelerate chemical reactions means enzymes are also used in a number of commercial processes, including brewing, food processing, domestic cleaning and paper manufacturing.

"Improving our fundamental knowledge of how enzymes work is important to a wide range of pharmaceutical and industrial fields," said Professor Nigel Scrutton, one of the lead researchers at Manchester.

"Enzymes are central to the existence of life because most chemical reactions in our cells would take place too slowly or produce a different outcome without their involvement.

"But when enzymes malfunction they can cause serious diseases, so modern drugs are designed to prevent enzymes accelerating, or 'catalysing', inappropriate reactions.

"Our research has shown at an atomic level how enzymes act as catalysts; the findings are a radical departure from the traditional view of how they work and might explain why attempts to make artificial enzymes have so far been disappointing.

The work � published as a major research article in the leading journal Science � builds on earlier studies by Professor Scrutton and Manchester colleagues, Professor Michael Sutcliffe and Dr David Leys.

Together they have shown, now in unprecedented detail, how enzymes avoid unfavourable energy barriers caused by the resistance to a reaction by allowing matter to 'flow through' the barrier � a process known as quantum mechanical tunnelling.

"We have provided new insight into how enzymes work from painstaking efforts of a large interdisciplinary group based on detailed experimental observations and theoretical analysis at the atomic level," said Professor Scrutton, who is based in the University's Faculty of Life Sciences.

"Modern drugs are designed to have structures that stick to enzymes and prevent them from catalysing the reactions, so our results need to be taken into account when designing new drugs.

"In the longer term, this research could also help us exploit enzymes more successfully and lead to better manufacturing processes in a number of commercial sectors.

"In cleaning products, for instance, enzymes help speed up the chemical reactions that break down protein and starch stains; a better understanding of how this process works could one day lead to more effective, faster acting agents."
 

- The research is published in Science on 14 April, 2006
 

www.manchester.ac.uk

 
Subscribe to Pharmacology Newsletter
E-mail Address:

 

Professor Nigel Scrutton and Dr David Leys are based in The University of Manchester's Faculty of Life Sciences; Professor Michael Sutcliffe, who is joint head of the project with Professor Scrutton, is based in Manchester's School of Chemical Engineering and Analytical Science. The University of Bristol group is headed by Dr A Mulholland

Related Pharmacology News

Phase Ib Trial Is Evaluating Bavituximab Administered With Common Chemotherapy Regimens
Two-component lantibiotic with therapeutic potential discovered
Prescription pain medication abuse on rise
Antibiotic inhibits cancer gene activity
NRTIs limits the atherogenic side effect of the protease inhibitors
Cyclin-dependent kinase inhibitors: The latest anti-inflammatory
FDA requested to promptly approve 17-P to prevent premature birth
Rapamycin shown to inhibit angiogenesis
Tigecycline, world�s first glycylcycline expanded broad-spectrum antibiotic, launched in UK
Ibuprofen - worsening cognitive function


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us